In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Metrics Inc.

Division of Mayne Pharma Group Ltd.
www.metricsinc.com

Latest From Metrics Inc.

Deals In Depth: October 2012

In a deal valued at $272 million, AZ got exclusive global rights to Ardelyx’s NHE3 program. Pfizer exercised an option to buy spec pharma NextWave for $255 million up front. Biophama companies raised almost $2 billion in October propelled by public offerings. Early venture rounds dominated device financing, which totaled $193 million.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, November 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Generic Drugs
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mayne Pharma Group Ltd.
  • Senior Management
  • Steve Taylor, CFO & VP, Fin. & Human Resources
    Jeffery C Basham, VP, Bus. Dev.
    William P Hodges, Pres.
    Michael D Ruff, VP, Pharma Dev.
  • Contact Info
  • Metrics Inc.
    Phone: (252) 752-3800
    1240 Sugg Pkwy.
    Greenvile, NC 27834
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register